Indigo Diabetes is a medtech company that develops a multi-biomarker sensor for people with diabetes.
Indigo Diabetes nv (Indigo) is a young high-tech medical device company founded by Danaë Delbeke and her team ended in 2016. Indigo develops the world’s first invisible sensor for people living with diabetes to address their need for accurate glucose monitoring with improved user experience. Indigo exploits groundbreaking photonics technology that revolutionized the Internet during the last decades and now aims at transforming diabetes management.
Announced Date | Round | Money Raised | Number of Investors | Lead Investors | Post Valuation | |
---|---|---|---|---|---|---|
Jul 27, 2020 | Series B | €38M | 5 | — | — | Detail |
Dec 20, 2016 | Series A | €7M | 2 | — | — | Detail |